| Kanetsky, Peter A |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers |
1R01CA291735-01 |
|
Claire Zhu, Ph.D. |
| Kanwal, Fasiha |
Baylor College Of Medicine
United States |
Risk Stratification for and Early Detection of Liver Cancer |
5U01CA230997-07 |
|
Sidney Fu, M.D. |
| Kassie, Fekadu |
University Of Minnesota
United States |
Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells |
5R01CA231210-05 |
|
Marjorie Perloff, M.D. |
| Katona, Bryson William |
University Of Pennsylvania
United States |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
5R21CA267949-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Asad Umar, D.V.M., Ph.D. |
| Kelleher, Sarah |
Duke University
United States |
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings |
5R21CA273832-02 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Kelleher, Sarah |
Duke University
United States |
Randomized Controlled Trial of a Hybrid-Delivered Cognitive Behavioral Symptom Management and Activity Coaching Intervention for Stem Cell Transplant Patients |
1R01CA291888-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Determinants of transdermal drug delivery to the normal and the radiated breast |
5R01CA235647-05 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
| Khan, Seema Ahsan |
Northwestern University At Chicago
United States |
Northwestern Cancer Prevention Consortium |
5UG1CA242643-06 |
|
Donald Johnsey |
| Khasabov, Sergey G |
University Of Minnesota
United States |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling |
5R01CA263777-04 |
|
Rachel Altshuler, Ph.D. |
| Kibel, Adam S |
Brigham And Women'S Hospital
United States |
Polygenic risk stratification combined with mpMRI to identify clinically relevant prostate cancer |
5U01CA268810-02 |
|
Richard Mazurchuk, Ph.D. |